<?xml version="1.0" encoding="UTF-8"?>
<p id="Par74">
 <list list-type="bullet">
  <list-item>
   <p id="Par75">History and Physical examination, including prior cancer therapies.</p>
  </list-item>
  <list-item>
   <p id="Par76">Restaging within 6â€‰weeks prior to enrolment:</p>
  </list-item>
  <list-item>
   <p id="Par77">Brain: CT or MRI for tumour sites with propensity for brain metastases. All patients with brain metastases (at enrolment or previously treated) require an MRI of the brain.</p>
  </list-item>
  <list-item>
   <p id="Par78">Body: CT neck/chest/abdomen/pelvis and bone scan is required. This may be replaced or supplemented with an appropriate PET/CT (i.e. 18-FDG or PSMA) for tumours where uptake is expected.</p>
  </list-item>
  <list-item>
   <p id="Par79">Additional imaging as clinically indicated</p>
  </list-item>
  <list-item>
   <p id="Par80">Complete blood count (Hemoglobin, white blood cell count, absolute neutrophil count, platelets).</p>
  </list-item>
  <list-item>
   <p id="Par81">Creatinine</p>
  </list-item>
  <list-item>
   <p id="Par82">Liver function tests (AST, ALT, GGT, alkaline phosphatase), albumin, bilirubin and INR for patients with liver metastases.</p>
  </list-item>
  <list-item>
   <p id="Par83">Pregnancy test for women of child-bearing age.</p>
  </list-item>
  <list-item>
   <p id="Par84">Completion of FACT-G and EQ-5D-5L quality of life forms.</p>
  </list-item>
  <list-item>
   <p id="Par85">Radiotherapy treatment plan has been reviewed by a physicist or radiation oncologist.</p>
  </list-item>
 </list>
</p>
